[1] |
Denton CP, Khanna D. Systemic sclerosis [J]. Lancet, 2017, pii: S0140⁃6736(17)30933⁃9. DOI: 10.1016/S0140⁃6736 (17) 30933⁃9.<br />
|
[2] |
van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheu⁃matology/European league against rheumatism collaborative initiative[J]. Arthritis Rheum, 2013, 65(11): 2737⁃2747. DOI: 10.1002/art.38098.<br />
|
[3] |
LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis[J]. J Rheumatol, 1988, 15(2): 202⁃205.<br />
|
[4] |
Steen VD, Medsger TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma[J]. Arthritis Rheum, 2000, 43(11): 2437⁃2444. DOI: 10.1002/1529⁃0131(200011)43:11<2437::AID⁃ANR10>3.0.CO;2⁃U.<br />
|
[5] |
Mathian A, Parizot C, Dorgham K, et al. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin⁃22 in systemic sclerosis lesions[J]. Ann Rheum Dis, 2012, 71(7): 1227⁃1234. DOI: 10.1136/annrheumdis⁃2011⁃200709.<br />
|
[6] |
Wangkaew S, Euathrongchit J, Wattanawittawas P, et al. Correla⁃tion of delta high⁃resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients[J]. Quant Imaging Med Surg, 2016, 6 (4): 381. DOI: 10.21037/qims. 2016.08.08.<br />
|
[7] |
Valentini G, Marcoccia A, Cuomo G, et al. Early systemic sclerosis: analysis of the disease course in patients with marker autoanti⁃body and/or capillaroscopic positivity[J]. Arthritis Care Res (Hoboken), 2014, 66(10): 1520⁃1527. DOI: 10.1002/acr.22304.<br />
|
[8] |
Wang J, Assassi S, Guo G, et al. Clinical and serological features of systemic sclerosis in a Chinese cohort[J]. Clin Rheumatol, 2013, 32(5): 617⁃621. DOI: 10.1007/s10067⁃012⁃2145⁃7.<br />
|
[9] |
Jaeger VK, Wirz EG, Allanore Y, et al. Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study[J]. PLoS One, 2016, 11(10): e0163894. DOI: 10.1371/journal.pone.0163894.<br />
|
[10] |
Barskova T, Gargani L, Guiducci S, et al. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis[J]. Ann Rheum Dis, 2013, 72(3): 390⁃395. DOI: 10.1136/annrheumdis⁃2011⁃201072.<br />
|
[11] |
Lepri G, Guiducci S, Bellando⁃Randone S, et al. Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre[J]. Ann Rheum Dis, 2015, 74(1): 124⁃128. DOI: 10.1136/annrheumdis⁃2013⁃203889.<br />
|
[12] |
Valentini G, Cuomo G, Abignano G, et al. Early systemic sclerosis: assessment of clinical and pre⁃clinical organ involvement in patients with different disease features[J]. Rheumatology (Oxford), 2011, 50(2): 317⁃323. DOI: 10.1093/rheumatology/keq176.<br />
|
[13] |
Khanna D, Nagaraja V, Tseng C, et al. Predictors of lung function decline in scleroderma⁃related interstitial lung disease based on high⁃resolution computed tomography: implications for cohort enrichment in systemic sclerosis⁃associated interstitial lung disease trials [J]. Arthritis Res Ther, 2015, 17(1): 372. DOI: 10.1186/s 13075⁃015⁃0872⁃2.<br />
|
[14] |
Nihtyanova SI, Schreiber BE, Ong VH, et al. Prediction of pulmonary complications and long⁃term survival in systemic sclerosis[J]. Arthritis Rheumatol, 2014, 66(6): 1625⁃1635. DOI: 10.1002/art.38390.<br />
|
[15] |
Bruni C, Guiducci S, Bellando⁃Randone S, et al. Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis[J]. Rheumatology (Oxford), 2015, 54(1): 72⁃76. DOI: 10.1093/rheumatology/keu296.<br />
|